SCHEMBL10429402

SCHEMBL10429402

CCOc1cc(O)c(C(=O)NCc2ccc(OC)cc2)c(OC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C19 P33261 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
HPGD P15428 2/20 0.51
LMNA P02545 1/20 0.51
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
MMP2 P08253 1/20 0.50
ALDH1A1 P00352 2/20 0.49
MMP3 P08254 1/20 0.49
MAPT P10636 1/20 0.49
KDM4E B2RXH2 1/20 0.48
SLC5A1 P13866 1/20 0.48
SLC5A2 P31639 1/20 0.48
POLB P06746 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
TP53 P04637 1/20 0.47
PDE4A P27815 1/20 0.47
PDE4B Q07343 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10961667 0.91 CYP3A4 (0.60) CYP3A4CYP2D6CYP2C19SMN1; SMN2HPGD
SCHEMBL10961164 0.91 SLC5A1 (0.50) CYP3A4CYP2D6CYP2C19SMN1; SMN2HPGD
SCHEMBL10959610 0.86 ALDH1A1 (0.50) CYP3A4CYP2D6CYP2C19HPGDKMT2A
SCHEMBL10964975 0.86 LMNA (0.51) CYP3A4CYP2D6CYP2C19HPGDLMNA
SCHEMBL10962644 0.85 AKR1C4 (0.47) CYP3A4CYP2D6CYP2C19SMN1; SMN2HPGD
SCHEMBL10960966 0.85 KMT2A (0.49) CYP3A4CYP2C19SMN1; SMN2HPGDLMNA
SCHEMBL10961929 0.84 HSD17B10 (0.48) SMN1; SMN2HPGDLMNAKMT2AMEN1
SCHEMBL11303954 0.84 ALDH1A1 (0.52) CYP3A4CYP2D6CYP2C19SMN1; SMN2HPGD
SCHEMBL10962656 0.83 CYP3A4 (0.46) CYP3A4CYP2D6CYP2C19SMN1; SMN2HPGD
SCHEMBL11297673 0.83 KDM4E (0.52) CYP3A4CYP2D6CYP2C19SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0051819-B1 TETRA-SUBSTITUTED BENZENE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1985-02-13 EP claimed
EP-0051819-A2 Tetra-substituted benzene derivatives, their preparation and pharmaceutical preparations containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-05-19 EP claimed
US-4956351-A INCLUSION COMPLEXESOFVIRICIDES; RHINITIS; SUSTAINED RELEASE; NONIRRITATING TO MUCOUS MEMBRANE JANSSEN PHARMACEUTICA N.V. FRAME-543 (BE) 1990-09-11 US disclosed
EP-0051819-B1 TETRA-SUBSTITUTED BENZENE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1985-02-13 EP disclosed
EP-0129747-A2 Thiazolidine derivatives, their preparation and intermediates therefor, and pharmaceutical preparations F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1985-01-02 EP disclosed
EP-0051819-A2 Tetra-substituted benzene derivatives, their preparation and pharmaceutical preparations containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-05-19 EP disclosed